Kailera Therapeutics (NAS: KLRA)

Waltham, MA · Founded 2024 · Publicly Held

Kailera Therapeutics Inc is a clinical-stage biotechnology company. Kailera Therapeutics (NAS: KLRA) is based in Waltham, MA and was founded in 2024. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $1.5 billion (Oct 2025). It has raised $1.6 billion.

Last price · $/share
—
Implied valuation
$1.5B
Total raised
$1.6B
Last round
—

Who backs Kailera Therapeutics (NAS: KLRA)?

14 investors
InvestorType
Qatar Investment AuthorityAsset manager
Bain CapitalPE / buyout
The Invus GroupPE / buyout
RTW InvestmentsHedge fund
Atlas VentureOther
Surveyor CapitalHedge fund
Bain Capital Life SciencesVenture capital
Adage Capital ManagementHedge fund
Lyra CapitalHedge fund
Canada Post Pension Plan—
+ 4 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Kailera Therapeutics (NAS: KLRA) investors

14 investors are on record for Kailera Therapeutics (NAS: KLRA), including Qatar Investment Authority, Bain Capital, The Invus Group and RTW Investments. By type, the record holds 4 hedge funds, 2 private equity firms and 1 venture capital firm.

Free account
More of Kailera Therapeutics (NAS: KLRA) with a free account
  • ·The complete investor list: 14 names
  • ·Watch Kailera Therapeutics (NAS: KLRA): the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 14 firms already write checks for companies like Kailera Therapeutics (NAS: KLRA). Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View